Product Categories
| Country: | China |
|---|---|
| Tel: | 18627753421 |
| Mobile: | +8618627756402 |
| E-mail: | 3001009495@qq.com |
| QQ: | 3001051413 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Creatine monohydrate | C4H11N3O3 | 6020-87-7 | Details |
| N, 1-bis (pyridine-4-yl) methylamine | C11H9N3 | 67038-99-7 | Details |
| 1-hydroxycyclobutyl carboxylic acid | C5H8O3 | 41248-13-9 | Details |
| 4-bromo-2-ethylpyridine | C7H8BrN | 156761-88-5 | Details |
| 2-amino-naphthalene intercalated diazine (heterobenzene) hydrogen chloride | C11H10BrN3 | 40835-96-9 | Details |
| 2-bromo-4,5,6, 7-tetrahydro1-benzothiophene | C8H9BrS | 111873-07-5 | Details |
| 2, 4-dimethoxy-N -(3-thiazolo-[5, 4-b] pyridine-2-phenyl) benzamide | C21H17N3O3S | 863589-44-0 | Details |
| 3-bromo-methyl-4-bromo-benzoate | C9H8Br2O2 | 142031-67-2 | Details |
| 3-[(4-chlorophenyl) sulfonyl] azacyclobutane hydrochloride | C9H11Cl2NO2S | 1820665-00-6 | Details |
| 3-bromo-7-hydroxy-1-naphthonitrile | C11H6BrNO | 550998-30-6 | Details |
| 3-hydroxy-5-methoxybenzoic acid | C8H8O4 | 19520-75-3 | Details |
| 7-chloro-1h-indazole-6-amine | C7H6ClN3 | 112635-08-2 | Details |
| 3-bromo-2-furanoic acid | C5H3BrO3 | 14903-90-3 | Details |
| Cis-trans-muconic acid | C6H6O4 | 1119-73-9 | Details |
| N, n-dimethyl methylamine iodide | C3H8IN | 33797-51-2 | Details |
| 8-chlorobenzopyran | C9H9ClO | 3722-69-8 | Details |
| 3-phenoxypropylamine | C9H13NO | 7617-76-7 | Details |
| N1-(3-amino-propyl) pentane-1, 5-diamine 3HCL | C8H22ClN3 | 90532-85-7 | Details |
| 2-(chloromethyl) methyl acrylate | C5H7ClO2 | 922-15-6 | Details |
| Cis-9, 10-methyleneoctadecanoic acid | C19H36O2 | 4675-61-0 | Details |
| 2-methyl-2-propyl (4-hydroxy-1-methylcyclohexyl) carbamate | C12H23NO3 | 792913-83-8 | Details |
| 5-chloro-7-nitro-indole | C8H5ClN2O2 | 1197181-29-5 | Details |
| Glycine, N, N '- [1 - (4, 5 - dimethoxy - 2 - nitro phenyl) - 1, 2 - ethyl 2 base] double [N - (carboxymethyl) - four sodium salt (cl) | C18H24N3NaO12 | 291517-40-3 | Details |
| 3-(aminomethyl) pyrazole | C4H7N3 | 37599-58-9 | Details |
| 6-amino-1-indone | C9H9NO | 69975-65-1 | Details |
| 3-ethyloxacyclophane-3-formaldehyde | C6H10O2 | 98485-37-1 | Details |
| Olanzapine impurity R | C15H18N4OS | 1320360-86-8 | Details |
| Olanzapine impurity Q | C17H20N4O2S | 1320360-87-9 | Details |
| C47H68O5 | Details |
| C25H38O4 | Details |
| C20H34O2 | C20H34O2 | 1191-41-9 | Details |
| C69H98O6 | Details |
| Moxidectin EP Impurity K | C44H56N2O11 | 174756-99-1 | Details |
| Cilnidipine Impurity 16 | C32H41N5O5 | 205448-66-5 | Details |
| Bromocriptine EP Impurity G | C32H40BrN5O5 | Details |
| Bromocriptine | C32H40BrN5O5 | 25614-03-3 | Details |
| Bromocriptine EP Impurity C | C32H40BrN5O5 | 65700-36-9 | Details |
| Bromocriptine EP Impurity F | C32H40BrN5O5 | 82773-21-5 | Details |
| Bromocriptine EP Impurity A | C32H40BrN5O5 | Details |
| Bromocriptine Impurity 10 | C32H40BrN5O5 | Details |
| Bromocriptine Impurity 12 | C33H42BrN5O5 | Details |
| Bromocriptine N-Oxide | Details |
| Bromocriptine Impurity 9 | Details |
| Valsartan Methyl Ester | C33H44BrN5O8S | 22260-51-1 | Details |
| Bromocriptine EP Impurity D | C16H15BrN2O2 | 478-83-1 | Details |
| 2-methyl-3-((7S,11S,Z)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione | Details |
| (E)-2-methyl-3-(3,7,11,15-tetramethylhexadec-1-en-1-yl)naphthalene-1,4-dione | Details |
| 2-methyl-3-((7R,11S,Z)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione | Details |
| Vitamin K1 Impurity 7 | C31H46O3 | 25486-55-9 | Details |
| Vitamin K1(7S,11R,E) isomer | C31H46O2 | 132487-95-7 | Details |
| 2-methyl-3-((7S,11R,Z)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione | Details |
| Vitamin K1(7S,11S,E) isomer | C31H46O2 | 132487-94-6 | Details |
| 2-methyl-5-methylene-2-((4R,8R)-4,8,12-trimethyltridecyl)-2H-benzo[h]chromen-6(5H)-one | C31H48O2 | 64236-23-3 | Details |
| (E)-2-(3-hydroxy-3,7,11,15-tetramethylhexadec-1-en-1-yl)-3-methylnaphthalene-1,4-dione | C13H12O3 | 2211-27-0 | Details |
| Vitamin K1(7R,11S,E) isomer | C31H46O2 | 132487-93-5 | Details |
| Vitamin K1 cis-isomer | C31H46O2 | 16033-41-3 | Details |
| Vitamin K1 impurity 6 | C11H8O3 | 15448-59-6 | Details |
| Vitamin K1 impurity 5 | C31H46O2 | 34044-00-3 | Details |
| Vitamin K1 impurity 3 | C18H36O | 502-69-2 | Details |
| Vitamin K1 Impurity 4 | C11H8O3 | 483-55-6 | Details |
| Ropiniero EP Impurity B(hydrochloride) | C16H25ClN2O | 221264-33-1 | Details |
| 4-(2-((2-methylpentyl)amino)ethyl)indolin-2-one | C16H24N2O | 249622-60-4 | Details |
| Ropiniero EP Impurity A(hydrochloride) | C16H23ClN2O2 | 221264-21-7 | Details |
| Ropiniero nitrogen oxide. | C16H24N2O2 | 1076199-41-1 | Details |
| Ropiniero EP Impurity D(hydrochloride) | C13H19ClN2O | 173990-76-6 | Details |
| Ropiniero EP Impurity C(hydrochloride) | C19H29ClN2O | 145570-92-9 | Details |
| 4-(2-(dipropylamino)ethyl)-3-methyleneindolin-2-one hydrochloride | Details |
| Ropinirole Impurity 8 | C17H26N2O2 | 1027600-42-5 | Details |
| Ropiniero EP Impurity G | C16H24N2 | 76149-15-0 | Details |
| Ropinirole Impurity 10 | C10H10ClNO | 168476-59-3 | Details |
| 4-(2-(dipropylamino)ethyl)-3-methyleneindolin-2-one | Details |
| 6-hydroxy-1-(4-(4-hydroxyphenyl)butan-2-yl)-1H-indol-5(7aH)-one | Details |
| Empagliflozin Impurity 133 | C23H27BrO7 | 2452301-12-9 | Details |
| Vitamin K1 Impurity 1 | C31H46O3 | 15576-40-6 | Details |
| Ropinirole Hydrochloride | C16H25ClN2O | 91374-20-8 | Details |
| Ropinirole EP Impurity D | C13H18N2O | 106916-16-9 | Details |
| Ropinirole EP Impurity F | C10H11NO2 | 139122-19-3 | Details |
| Upatinib Impurity 93 | C16H21NO3 | 2411540-29-7 | Details |
| Vericiguat | C19H16F2N8O2 | 1350653-20-1 | Details |
| Lactate tetramer | C20H24N2O6 | 1985607-65-5 | Details |
| Baloxavir Impurity 79. | C14H10F2O2S | 2757707-17-6 | Details |
| Cytarabine impurity 7 | C17H19N5O8 | 82855-62-7 | Details |
| Tafluprost Impurity E | C25H34F2O5 | 1563176-58-8 | Details |
| Tafluprost Impurity 3 | C23H24BrO2P | 17814-85-6 | Details |
| Verapamil EP Impurity C HCl | C12H20ClNO2 | 51012-67-0 | Details |
| Upadacitinib Impurity 5 | C20H21F6N7O2 | 2715120-86-6 | Details |
| Upadacitinib Impurity 46 | C13H12N4O2S | 1201187-46-3 | Details |
| Oseltamivir impurity 130 | C14H24O5 | 2097777-49-4 | Details |
| Nemonoxacin Impurity 6 | C12H12F2O4 | 221221-12-1 | Details |
| Bisoprolol Impurity 9 | C16H25NO5 | 1346602-59-2 | Details |
| Sugammadex sodium Decomposition process Impurity 3 | C6H10O4S2 | 1119-62-6 | Details |
| I030004 | C19H18N4O3S | 172152-37-3 | Details |
| Upadacitinib Impurity 7 | C14H17N5 | 1708997-43-6 | Details |
| Phthalamic Acid | C19H18N4OS | 172152-35-1 | Details |
| Ilaprazole Impurity 16 | C27H27N5O2S | 1360824-56-1 | Details |
| Linagliptin Impurity 45 | C21H21N7O2 | 2468656-63-3 | Details |
| Upadacitinib Impurity 4 | C34H39N5O7S | 1428243-27-9 | Details |
| Linagliptin Impurity CD10100 | C16H20BrNO3 | 2304514-69-8 | Details |
| 7-((3R,5R)-3-amino-5-methylpiperidin-1-yl)-1-cyclopropyl-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | C20H25N3O4 | 378746-65-7 | Details |
| Linagliptin Impurity CD10102 | C11H9N3O | 1018229-53-2 | Details |
| Product Total： Product Page： | ||||
| 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 | ||||